High Prevalence of Cancer and Effectiveness of Stem Cells from Umbilical Cord Blood in Treatment of Various Diseases to Boost Demand for Cord Blood Banking Services

 

A cord blood banking services offer storage of umbilical cord blood exclusively for possible use in the future for the treatment of diseases of the blood and immune systems. The stem cells obtained from cord blood are extremely rich in proteins and enzymes, and have the highest levels of integrity and exactitude among any sources available today. In fact, it may be more valuable than DNA or gene samples, as it contains the most exact match between identical twins. The potential benefits for stem cell transplants are endless. However, because stem cells are so unique, there is some worry about whether they will be accepted and stored responsibly by the medical industry.

Since stem cells obtained from umbilical cords are still in the earliest stages of development, they are not mature enough to be stored in most storage facilities. Stem cells are typically taken from the umbilical cord after the child has been born, during the last month of pregnancy. Cord blood banking services are viable only once the child is born, ideally when he or she has been immunized and starts to nurse. The process of getting a cord blood banking specimen completed, preserving it and then storing it is an incredibly complicated procedure, one that must be performed with care.

There are two main storage facilities used for storing umbilical cord blood: cord blood delivery and cord blood collecting. While cord blood delivery is extremely safe and effective, collecting your baby's cord blood yourself can be a risky endeavor. The procedure involves taking a sample of your baby's umbilical cord blood, freezing it within hours of birth and then gathering it safely over the following few weeks.

Recent research has demonstrated the potential usefulness of stem cells from umbilical cord blood in the treatment of diseases like leukemia and Parkinson's disease. Moreover, high prevalence of cancer is expected to boost demand for cord blood bank services. For instance, according to the World Health Organization, Germany recorded 628,519 new cases of cancer and 252,065 deaths in 2020. Such scenario has led to increasing demand for cord blood banking services and products, thereby prompting market players to introduce new offerings. For instance, in July 2019, Americord Registry launched Placental Tissue 2.0, its newest stem cell banking product, which stores live amniotic membrane.